MARKET

CORT

CORT

Corcept Therapeutics Inc
NASDAQ
38.53
-1.94
-4.79%
After Hours: 38.90 +0.37 +0.96% 19:28 03/26 EDT
OPEN
38.76
PREV CLOSE
40.47
HIGH
40.12
LOW
37.88
VOLUME
3.03M
TURNOVER
--
52 WEEK HIGH
117.33
52 WEEK LOW
28.66
MARKET CAP
4.10B
P/E (TTM)
46.39
1D
5D
1M
3M
1Y
5Y
1D
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
PR Newswire · 6h ago
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
PR Newswire · 12h ago
Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity
Dow Jones · 17h ago
Corcept Therapeutics Price Target Raised to $110.00/Share From $100.00 by Canaccord Genuity
Dow Jones · 17h ago
Canaccord Genuity Maintains Buy on Corcept Therapeutics, Raises Price Target to $110
Benzinga · 18h ago
Corcept Therapeutics Raised to Peer Perform From Underperform by Wolfe Research
Dow Jones · 18h ago
Wolfe Research Upgrades Corcept Therapeutics to Peer Perform
Benzinga · 18h ago
Corcept Therapeutics upgraded to Peer Perform from Underperform at Wolfe Research
TipRanks · 20h ago
More
About CORT
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.

Webull offers Corcept Therapeutics Inc stock information, including NASDAQ: CORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORT stock methods without spending real money on the virtual paper trading platform.